• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯疱疹病毒(HSV)蛋白ICP34.5是一种病毒体成分,它与增殖细胞核抗原和HSV复制蛋白形成DNA结合复合物。

The herpes simplex virus (HSV) protein ICP34.5 is a virion component that forms a DNA-binding complex with proliferating cell nuclear antigen and HSV replication proteins.

作者信息

Harland June, Dunn Paul, Cameron Euan, Conner Joe, Brown S Moira

机构信息

Glasgow University, Neurovirology Research Laboratories, Institute of Neurological Sciences, Southern General Hospital, Glasgow, United Kingdom.

出版信息

J Neurovirol. 2003 Aug;9(4):477-88. doi: 10.1080/13550280390218788.

DOI:10.1080/13550280390218788
PMID:12907392
Abstract

The replicative ability of ICP34.5-null herpes simplex virus (HSV) is cell type and state dependent. In certain cells, ICP34.5 interacts with protein phosphatase 1 to preclude host cell protein synthesis shutoff by dephosphorylation of the eukaryotic initiation factor eIF-2alpha. However, host cell shutoff is not induced by ICP34.5-null HSV in most cells, irrespective of type and state. In general, dividing cells support replication of ICP34.5-null HSV; nondividing cells cannot. Previously the authors showed that ICP34.5 binds to proliferating cell nuclear antigen (PCNA), a protein necessary for cellular DNA replication and repair. Here the authors demonstrate that (1) the interaction between ICP34.5 and PCNA involves two regions of the virus protein; (2) ICP34.5 forms a complex with HSV replication proteins that is DNA binding; (3) at early times in infection, ICP34.5 colocalizes with PCNA and HSV replication proteins in cell nuclei, before accumulating in the cytoplasm; and (4) ICP34.5 is a virion protein. In light of ongoing clinical trials assessing the safety and efficacy of ICP34.5-null HSV, it is vital that the roles of ICP34.5 in HSV replication are understood. The authors propose that in nondividing cells, ICP34.5 is required to switch PCNA from repair to replication mode, a prerequisite for the initiation of HSV replication.

摘要

缺失 ICP34.5 的单纯疱疹病毒(HSV)的复制能力取决于细胞类型和状态。在某些细胞中,ICP34.5 与蛋白磷酸酶 1 相互作用,通过使真核起始因子 eIF-2α 去磷酸化来防止宿主细胞蛋白质合成的关闭。然而,无论细胞类型和状态如何,大多数细胞中缺失 ICP34.5 的 HSV 都不会诱导宿主细胞关闭。一般来说,分裂细胞支持缺失 ICP34.5 的 HSV 的复制;非分裂细胞则不能。此前作者表明 ICP34.5 与增殖细胞核抗原(PCNA)结合,PCNA 是细胞 DNA 复制和修复所必需的一种蛋白质。在此作者证明:(1)ICP34.5 与 PCNA 之间的相互作用涉及病毒蛋白的两个区域;(2)ICP34.5 与 HSV 复制蛋白形成一种具有 DNA 结合能力的复合物;(3)在感染早期,ICP34.5 在积聚于细胞质之前,与 PCNA 和 HSV 复制蛋白在细胞核中共定位;(4)ICP34.5 是一种病毒体蛋白。鉴于正在进行评估缺失 ICP34.5 的 HSV 的安全性和有效性的临床试验,了解 ICP34.5 在 HSV 复制中的作用至关重要。作者提出,在非分裂细胞中,需要 ICP34.5 将 PCNA 从修复模式转换为复制模式,这是启动 HSV 复制的先决条件。

相似文献

1
The herpes simplex virus (HSV) protein ICP34.5 is a virion component that forms a DNA-binding complex with proliferating cell nuclear antigen and HSV replication proteins.单纯疱疹病毒(HSV)蛋白ICP34.5是一种病毒体成分,它与增殖细胞核抗原和HSV复制蛋白形成DNA结合复合物。
J Neurovirol. 2003 Aug;9(4):477-88. doi: 10.1080/13550280390218788.
2
Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response.单纯疱疹病毒1型对宿主固有免疫反应的对抗作用的功能基因组分析
J Virol. 2006 Aug;80(15):7600-12. doi: 10.1128/JVI.00333-06.
3
The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34.单纯疱疹病毒毒力因子ICP34.5与细胞蛋白MyD116通过ICP34.5、MyD116和GADD34中保守的63个氨基酸结构域与增殖细胞核抗原形成复合物。
J Virol. 1997 Dec;71(12):9442-9. doi: 10.1128/JVI.71.12.9442-9449.1997.
4
Analysis of the role of autophagy in replication of herpes simplex virus in cell culture.自噬在单纯疱疹病毒细胞培养复制中的作用分析
J Virol. 2007 Nov;81(22):12128-34. doi: 10.1128/JVI.01356-07. Epub 2007 Sep 12.
5
Early nucleosome deposition on, and replication of, HSV DNA requires cell factor PCNA.单纯疱疹病毒(HSV)DNA上早期核小体的沉积及复制需要细胞因子增殖细胞核抗原(PCNA)。
J Neurovirol. 2015 Aug;21(4):358-69. doi: 10.1007/s13365-015-0321-7. Epub 2015 Feb 12.
6
Up to four distinct polypeptides are produced from the γ34.5 open reading frame of herpes simplex virus 2.从单纯疱疹病毒 2 的 γ34.5 开放阅读框可产生多达四种不同的多肽。
J Virol. 2014 Oct;88(19):11284-96. doi: 10.1128/JVI.01284-14. Epub 2014 Jul 16.
7
The herpes simplex virus 1 UL36USP deubiquitinase suppresses DNA repair in host cells via deubiquitination of proliferating cell nuclear antigen.单纯疱疹病毒1型UL36USP去泛素化酶通过使增殖细胞核抗原去泛素化来抑制宿主细胞中的DNA修复。
J Biol Chem. 2017 May 19;292(20):8472-8483. doi: 10.1074/jbc.M117.778076. Epub 2017 Mar 27.
8
Increased eIF2alpha phosphorylation attenuates replication of herpes simplex virus 2 vhs mutants in mouse embryonic fibroblasts and correlates with reduced accumulation of the PKR antagonist ICP34.5.真核生物翻译起始因子2α(eIF2α)磷酸化增加可减弱单纯疱疹病毒2型(HSV-2)vhs突变体在小鼠胚胎成纤维细胞中的复制,并与PKR拮抗剂ICP34.5积累减少相关。
J Virol. 2009 Sep;83(18):9151-62. doi: 10.1128/JVI.00886-09. Epub 2009 Jul 8.
9
ICP34.5 protein of herpes simplex virus facilitates the initiation of protein translation by bridging eukaryotic initiation factor 2alpha (eIF2alpha) and protein phosphatase 1.单纯疱疹病毒 ICP34.5 蛋白通过桥接真核起始因子 2α(eIF2α)和蛋白磷酸酶 1 促进蛋白质翻译的起始。
J Biol Chem. 2011 Jul 15;286(28):24785-92. doi: 10.1074/jbc.M111.232439. Epub 2011 May 26.
10
ICP34.5 influences herpes simplex virus type 1 maturation and egress from infected cells in vitro.ICP34.5在体外影响单纯疱疹病毒1型的成熟及从受感染细胞中的释放。
J Gen Virol. 1994 Dec;75 ( Pt 12):3679-86. doi: 10.1099/0022-1317-75-12-3679.

引用本文的文献

1
Advanced progress in the genetic modification of the oncolytic HSV-1 virus.溶瘤性单纯疱疹病毒1型(HSV-1)基因改造的前沿进展。
Front Oncol. 2025 Jan 21;14:1525940. doi: 10.3389/fonc.2024.1525940. eCollection 2024.
2
The precise function of alphaherpesvirus tegument proteins and their interactions during the viral life cycle.甲型疱疹病毒被膜蛋白在病毒生命周期中的精确功能及其相互作用。
Front Microbiol. 2024 Jul 2;15:1431672. doi: 10.3389/fmicb.2024.1431672. eCollection 2024.
3
Inflammation and viral infection as disease modifiers in schizophrenia.

本文引用的文献

1
Who binds wins: Competition for PCNA rings out cell-cycle changes.谁结合谁赢:PCNA 环的竞争敲响了细胞周期变化的警钟。
Trends Cell Biol. 1997 Dec;7(12):493-8. doi: 10.1016/S0962-8924(97)01170-7.
2
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study.瘤内注射改良型(ICP 34.5(-))单纯疱疹病毒HSV1716治疗人类恶性胶质瘤的疗效潜力:一项原理验证研究。
Gene Ther. 2002 Mar;9(6):398-406. doi: 10.1038/sj.gt.3301664.
3
The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma.
炎症和病毒感染作为精神分裂症的疾病修饰因素
Front Psychiatry. 2023 Oct 2;14:1231750. doi: 10.3389/fpsyt.2023.1231750. eCollection 2023.
4
Interplay between Autophagy and Herpes Simplex Virus Type 1: ICP34.5, One of the Main Actors.自噬与单纯疱疹病毒 1 型的相互作用:ICP34.5,主要参与者之一。
Int J Mol Sci. 2022 Nov 7;23(21):13643. doi: 10.3390/ijms232113643.
5
HSV-1 DNA Replication-Coordinated Regulation by Viral and Cellular Factors.单纯疱疹病毒 1 型 DNA 复制-病毒和细胞因子的协调调节。
Viruses. 2021 Oct 7;13(10):2015. doi: 10.3390/v13102015.
6
Oncolytic virus therapy in cancer: A current review.癌症中的溶瘤病毒疗法:当前综述
World J Virol. 2021 Sep 25;10(5):229-255. doi: 10.5501/wjv.v10.i5.229.
7
Qualitative Differences in Capsidless L-Particles Released as a By-Product of Bovine Herpesvirus 1 and Herpes Simplex Virus 1 Infections.无衣壳 L 颗粒作为牛疱疹病毒 1 和单纯疱疹病毒 1 感染的副产物释放的定性差异。
J Virol. 2018 Oct 29;92(22). doi: 10.1128/JVI.01259-18. Print 2018 Nov 15.
8
Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma.对一种编码粒细胞-巨噬细胞集落刺激因子的溶瘤性疱疹病毒治疗恶性黑色素瘤的批判性分析。
Oncolytic Virother. 2014 Jan 15;3:11-20. doi: 10.2147/OV.S36701. eCollection 2014.
9
Fluorescent Protein Approaches in Alpha Herpesvirus Research.甲型疱疹病毒研究中的荧光蛋白方法。
Viruses. 2015 Nov 19;7(11):5933-61. doi: 10.3390/v7112915.
10
Designing Herpes Viruses as Oncolytics.将疱疹病毒设计为溶瘤病毒
Mol Ther Oncolytics. 2015;2:15010-. doi: 10.1038/mto.2015.10. Epub 2015 Jul 22.
使用基因工程改造的单纯疱疹病毒(R7020)联合电离辐射用于实验性肝癌研究。
Gene Ther. 2002 Jan;9(1):75-80. doi: 10.1038/sj.gt.3301620.
4
A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals.一种1型单纯疱疹病毒γ34.5第二位点抑制突变体,在培养的胶质母细胞瘤细胞中生长增强,但在动物体内则严重减毒。
J Virol. 2001 Jun;75(11):5189-96. doi: 10.1128/JVI.75.11.5189-5196.2001.
5
Intralesional injection of herpes simplex virus 1716 in metastatic melanoma.
Lancet. 2001 Feb 17;357(9255):525-6. doi: 10.1016/S0140-6736(00)04048-4.
6
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.用于治疗恶性胶质瘤的条件性复制单纯疱疹病毒突变体G207:I期试验结果
Gene Ther. 2000 May;7(10):867-74. doi: 10.1038/sj.gt.3301205.
7
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma.具有复制能力的单纯疱疹病毒(ICP 34.5缺失突变体1716)在复发性恶性胶质瘤患者中的毒性评估。
Gene Ther. 2000 May;7(10):859-66. doi: 10.1038/sj.gt.3301184.
8
Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene.通过敲除宿主抗性基因实现减毒病毒的特定表型恢复。
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6097-101. doi: 10.1073/pnas.100415697.
9
MyD genes in negative growth control.负生长调控中的MyD基因
Oncogene. 1998 Dec 24;17(25):3319-29. doi: 10.1038/sj.onc.1202574.
10
Histopathological responses in the CNS following inoculation with a non-neurovirulent mutant (1716) of herpes simplex virus type 1 (HSV 1): relevance for gene and cancer therapy.接种单纯疱疹病毒1型(HSV 1)的非神经毒力突变株(1716)后中枢神经系统的组织病理学反应:与基因治疗和癌症治疗的相关性。
Neuropathol Appl Neurobiol. 1998 Oct;24(5):367-72. doi: 10.1046/j.1365-2990.1998.00133.x.